 HIGH POINT, N.C., March 08, 2021 GLOBE NEWSWIRE -- vTv Therapeutics Inc. Nasdaq: VTVT a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diabetes and inflammatory diseases, today announced its participation in the H.C. Wainwright Global Life Sciences Conference held virtually March 9-10, 2021. 